Skip to main content

Arcturus Therapeutics Holdings Inc.

corporate_fare Company Profile

Arcturus Therapeutics Holdings Inc.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ARCT - Latest Insights

ARCT
Mar 03, 2026, 4:34 PM EST
Filing Type: 10-K
Importance Score:
9
Arcturus Faces Major Setbacks: CSL Write-Down, FDA Delay for KOSTAIVE, and Revenue Decline
Sentiment: Negative
View Wiseek Article
ARCT
Mar 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Arcturus Therapeutics Reports $1.03 Per Share Loss for Q4
Sentiment: Negative
View Wiseek Article